-

William Blair Expands Biopharma Investment Banking Group With Senior Hire

CHICAGO--(BUSINESS WIRE)--William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, today announced the addition of Terence Tan as managing director in the firm’s Healthcare investment banking team. Based in New York, Tan will focus on providing biopharma companies with comprehensive advisory services.

“It is my pleasure to welcome Terence to William Blair’s Healthcare investment banking practice and its biopharma group,” said Steve Tole, head of Healthcare investment banking at William Blair. “Our team of committed bankers provides strategic investors and financial sponsors with unique sector expertise and tailored advisory services across the fast-paced biopharma industry, including its various complex subsectors, and Terence’s addition will further deepen our capabilities and commitment to our clients.”

Tan brings more than 19 years of experience in biopharma investment banking, serving companies across all stages of development. He joins from Cantor Fitzgerald, where he served as a managing director focused on providing biopharma companies with investment banking guidance, including debt, equity, and equity-linked securities, private placements, and mergers and acquisitions. Tan has worked closely with venture capital firms, hedge funds, and mutual funds to unlock sophisticated financing solutions, having also held roles with Jefferies and UBS. He received his B.S. from Cornell University.

“William Blair is well-known for its premier investment banking platform, thoughtful client service, and innovative solutions to leading biopharma companies,” Tan said. “I am thrilled to join such a well-respected team and to deliver outstanding outcomes for our clients.”

About William Blair Investment Banking

William Blair’s investment banking group enables corporations, financial sponsors, and owner/entrepreneurs around the world to achieve their growth, liquidity, and financing objectives. Drawing on the collective intellectual capital and deep sector expertise of a global team that reaches over 20 cities on four continents, the investment banking group brings a rigorous and innovative approach to corporate board advisory projects, mergers and acquisitions, and equity and debt financing. From January 2020 to December 2024, the team advised on more than $810 billion in completed transaction volume.

About William Blair

William Blair is the premier global boutique with expertise in investment banking, investment management, and private wealth management. We provide advisory services, strategies, and solutions to meet our clients’ evolving needs. As an independent and employee-owned firm, together with our strategic partners, we operate in more than 20 offices worldwide.*

*Includes strategic partnerships with Allier Capital, BDA Partners, and Poalim Capital Markets.

William Blair


Release Summary
Terence Tan Joins William Blair's Biopharma Investment Banking Group in New York
Release Versions

More News From William Blair

William Blair Investment Management Launches Global Leaders Select Strategy, Appoints Chandan Khanna as Co-Portfolio Manager

LONDON--(BUSINESS WIRE)--William Blair Investment Management today announced the launch of the Global Leaders Select Strategy, with the appointment of Chandan Khanna as Co-Portfolio Manager alongside Hugo Scott-Gall, Head of William Blair’s Global Equity Team. The Global Leaders Select strategy is a concentrated portfolio of 25-35 leading global companies which combine quality and growth characteristics. The strategy is benchmark-agnostic and aims to deliver strong long-term returns for investo...

William Blair Hires Head of Biopharma Investment Banking, based in New York

NEW YORK--(BUSINESS WIRE)--William Blair announced today the expansion of the firm’s Healthcare team with the addition of Michael Allwin as managing director and head of Biopharma investment banking. Based in New York, Allwin will lead the firm’s global efforts to provide comprehensive advisory services to public and private biopharma companies across all stages of development as well as financial sponsors and venture firms focused on the sector. “Michael will play a critical role in further ex...

William Blair Investment Management Appoints Olga Bitel as Chief Investment Strategist

CHICAGO--(BUSINESS WIRE)--William Blair Investment Management announced today the appointment of Olga Bitel as Chief Investment Strategist. In this newly established role, Bitel will help shape William Blair Investment Management’s investment perspective across global markets and economies, drawing on the firm’s broad investment expertise to provide investors with insight into the forces influencing portfolio outcomes and long-term investment opportunities.As Chief Investment Strategist, Olga wi...
Back to Newsroom